Phio Pharmaceuticals PHIO
NASDAQ PHIO
$0.91 +0.02 (+2.80%)
As of: Oct 21, 2026 · 3:59 PM EDT

Phio Pharmaceuticals (PHIO) Convertible Debt (2011 - 2012)

Updated

Phio Pharmaceuticals (PHIO) recorded Convertible Debt of $1 million in Q1 2012, up 100.0% from the prior quarter.

Analysis

Phio Pharmaceuticals (PHIO) Convertible Debt (2011 - 2012) Analysis & Trends

At the end of FY2011, Phio Pharmaceuticals reported Convertible Debt of $500,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Phio Pharmaceuticals 10.57 Mn -51.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 1.00 Mn
Dec 31, 2011 500,000.00
API Access

Phio Pharmaceuticals Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=PHIO&period=max&api_key=YOUR_API_KEY